Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Teckro is an Irish enterprise software company serving pharmaceutical companies, biotech firms, CROs, and clinical research teams. It addresses two common challenges in clinical trials: site teams not having enough time, and sponsors lacking visibility. The platform digitizes site engagement, communications, protocol Q&A, training, and the return of patient data, helping sponsors move from reactive support to proactive management based on performance data.
Based on the available content, Teckro’s core proposition is “data-driven site performance.” Its features include site engagement analytics, Site Performance Quadrant, site sentiment, communication signals, Protocol analytics, intelligent search, mobile-first training, targeted communications, and connected communications. FAQ Copilot uses generative AI to provide CRAs with compliant answers from approved study FAQs, reducing FAQ spreadsheets and repetitive communication. Its patient experience offering also emphasizes secure patient data return, patient management workflows, and real-time engagement insights.
The website does not publish plans, unit pricing, or billing methods. Solutions are mainly accessed via Request demo / Book a demo, which is consistent with the sales model for large-scale life sciences enterprise software. Public materials mention premium service and expert-designed data-driven interventions, but do not specify service tiers, implementation timelines, or support SLAs.
Teckro clearly emphasizes that it operates in a highly regulated environment, with data protection and sponsor governance at the core, aligned with internal standards, processes, and risk frameworks. Its terms of service require users not to share accounts or download or distribute sponsor content without authorization, and state that application usage may be monitored to ensure compliance. Deployment model, third-party integrations, APIs, and developer support are not disclosed, making these key areas to investigate during technical due diligence.
Its strengths are deep vertical focus, real-time data and measurable metrics around clinical trial site performance, and a mobile-first experience that can help improve site adoption. Its weaknesses are that public information is relatively marketing-oriented, with limited details on pricing, integrations, permissions, and China localization. Teckro is best suited to global pharmaceutical companies, biotech firms, and CROs running complex, multi-site, multinational clinical trials. It is not a fit for teams looking for general project management or standard enterprise collaboration software.
The available text does not provide information on access from mainland China, payment methods, data residency, or local compliance, so china_access can only be rated as unknown. For deployment at research centers in China, key items to verify include network connectivity, mobile usability, cross-border data transfer, privacy compliance, payment, and contracting entity. Comparable clinical trial technology platforms include Medidata, Veeva Vault Clinical, and Oracle Clinical One.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on teckro.com official site.
teckro.com is an Ireland Health provider. TG4G tracks its product information, an overall rating of 7.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach teckro.com directly.